Clinical Trial Spotlight: Targeting Brain Mets in EGFR Lung Cancer Patients

cancergrace has 1140 videos Subscribe Here

Description: Dr. Ross Camidge talks about a clinical trial that will test to see if the drug tesevatinib will work to kill cancer that has progressed in the brains of EGFR-mutant lung cancer patients. The trial is scheduled to begin in late 2015 or early 2016.

November is Lung Cancer Awareness Month. What are you grateful for? #LCAM15 #Gratitude
Shared By : cancergrace
Posted on : 11/27/15
Added : 4 years ago